Conference
Efficacy And Safety Of Nintedanib In Patients With Idiopathic Pulmonary Fibrosis: Results Of Two 52-Week, Phase Iii, Randomized, Placebo-Controlled Trials (inpulsis (TM))
Authors
Richeldi L; Du Bois R; Raghu G; Azuma A; Brown KK; Costabel U; Cottin V; Flaherty K; Inoue Y; Kim D
Volume
189
Publisher
AMER THORACIC SOC
Publication Date
January 1, 2014
Conference proceedings
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
ISSN
1073-449X